| For: | Panera N, Gnani D, Crudele A, Ceccarelli S, Nobili V, Alisi A. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(41): 15079-15086 [PMID: 25386056 DOI: 10.3748/wjg.v20.i41.15079] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15079.htm |
| Number | Citing Articles |
| 1 |
Chengjun Wei, Hongxia Zhang, Chenghong Wei, Youyan Mao. Correlation of the expression of miR-146a in peripheral blood mononuclear cells of patients with ankylosing spondylitis and inflammatory factors. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5155
|
| 2 |
Luigi Elio Adinolfi, Luca Rinaldi, Alessandra Marrazzo, Mauro Maurantonio, Fabio Nascimbeni, Amedeo Lonardo. Nonalcoholic fatty liver disease: Evolving paradigms. World Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
|
| 3 |
Usman Umar Liman, Asanka Sudeshini Hawage, Sumadee De Silva, Saumya Madushani Samarasinghe, Kamani Hemamala Tennekoon, Rohan Chaminda Siriwardana, Madunil Anuk Niriella. Pathogenic effects of telomerase reverse transcriptase (TERT) promoter mutations in nonalcoholic steatohepatitis (NASH) related hepatocellular carcinoma (HCC) and its potentials as a diagnostic biomarker. Egyptian Journal of Medical Human Genetics 2025; 26(1) doi: 10.1186/s43042-025-00738-z
|
| 4 |
Teresa Auguet, Gemma Aragonès, Alba Berlanga, Esther Guiu-Jurado, Andreu Martí, Salomé Martínez, Fàtima Sabench, Mercé Hernández, Carmen Aguilar, Joan Sirvent, Daniel Del Castillo, Cristóbal Richart. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(10) doi: 10.3390/ijms17101620
|
| 5 |
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular Regulation of Mirnas and Potential Biomarkers in the Progression of Hepatic Steatosis to NASH. Biomarkers in Medicine 2015; 9(11) doi: 10.2217/bmm.15.70
|
| 6 |
Hyun Yi Kook, So‐Hee Jin, Pu‐Reum Park, Seung‐Jin Lee, Hong‐Joon Shin, Tae‐Jong Kim. Serum miR‐214 as a novel biomarker for ankylosing spondylitis. International Journal of Rheumatic Diseases 2019; 22(7) doi: 10.1111/1756-185X.13475
|
| 7 |
Carla Bizzarri, Rita M. Pinto, Sara Ciccone, Letizia P. Brescia, Franco Locatelli, Marco Cappa. Early and progressive insulin resistance in young, non‐obese cancer survivors treated with hematopoietic stem cell transplantation. Pediatric Blood & Cancer 2015; 62(9) doi: 10.1002/pbc.25603
|
| 8 |
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. International Journal of Molecular Sciences 2018; 19(12) doi: 10.3390/ijms19123966
|
| 9 |
Anurag Mishra, Adiba Nizam, Rajdeep Singh. Gallbladder Cancer. 2023; doi: 10.1007/978-981-19-6442-8_11
|
| 10 |
Rodica Talmaci. miRNA – molecular biomarkers in non-alcoholic fatty liver disease: potential targets in nutritional interventions. Dietetician.ro 2023; 3(3) doi: 10.26416/Diet.3.3.2023.8754
|
| 11 |
|
| 12 |
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver disease. Molecular Aspects of Medicine 2017; 54 doi: 10.1016/j.mam.2016.11.008
|
| 13 |
Marica Meroni, Miriam Longo, Veronica Erconi, Luca Valenti, Stefano Gatti, Anna Ludovica Fracanzani, Paola Dongiovanni. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. Nutrients 2019; 11(11) doi: 10.3390/nu11112597
|
| 14 |
Bruno de Souza Goncalves, Avery Meadows, Duane G. Pereira, Raghav Puri, Sneha S. Pillai. Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. Biomedicines 2023; 11(6) doi: 10.3390/biomedicines11061597
|
| 15 |
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. Annals of Hepatology 2021; 21 doi: 10.1016/j.aohep.2020.04.012
|
| 16 |
Fengqiong Liu, Qing Chen, Fa Chen, Jing Wang, Ruijie Gong, Baochang He. The lncRNA ENST00000608794 acts as a competing endogenous RNA to regulate PDK4 expression by sponging miR-15b-5p in dexamethasone induced steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(10) doi: 10.1016/j.bbalip.2019.07.003
|
| 17 |
|
| 18 |
Yanhua Zhang, Yuqin Wei, Huan Liu, Yanju Guo. Protective effect of exercise on metabolic dysfunction‑associated fatty liver disease: Potential epigenetic mechanisms (Review). International Journal of Molecular Medicine 2025; 56(4) doi: 10.3892/ijmm.2025.5587
|
| 19 |
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutrition Research Reviews 2019; 32(1) doi: 10.1017/S0954422418000239
|
| 20 |
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. Biomedicines 2021; 9(11) doi: 10.3390/biomedicines9111524
|
| 21 |
Rajani Rai, Balraj Mittal, Jong Joo Kim, Vishal Chandra. MicroRNA aberrations: An emerging field for gallbladder cancer management. World Journal of Gastroenterology 2016; 22(5): 1787-1799 doi: 10.3748/wjg.v22.i5.1787
|
| 22 |
Fernanda Torres Quitete, Ananda Vitória Silva Teixeira, Thamara Cherem Peixoto, Bruna Cadete Martins, Geórgia Correa Atella, Angela de Castro Resende, Daniela de Barros Mucci, Fabiane Martins, Julio Beltrame Daleprane, Partha Mukhopadhyay. Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice. PLOS ONE 2024; 19(8) doi: 10.1371/journal.pone.0308334
|
| 23 |
Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou, Yunxia Li. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic
Fatty Liver Disease: A Review on Molecular Mechanisms. Current Molecular Pharmacology 2022; 15(6) doi: 10.2174/1874467215666211217120448
|
| 24 |
Fatemeh Kalaki-Jouybari, Mehrnoosh Shanaki, Maryam Delfan, Sattar Gorgani-Firouzjae, Soheyla Khakdan. High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. Archives of Physiology and Biochemistry 2020; 126(3) doi: 10.1080/13813455.2018.1510968
|
| 25 |
Junjie Xiao, Dongchao Lv, Yingying Zhao, Xiaoyu Chen, Meiyi Song, Jingqi Liu, Yihua Bei, Fei Wang, Wenzhuo Yang, Changqing Yang. miR‐149 controls non‐alcoholic fatty liver by targeting FGF‐21. Journal of Cellular and Molecular Medicine 2016; 20(8) doi: 10.1111/jcmm.12848
|
| 26 |
Li Su, Mingmei Liu. Correlation analysis on the expression levels of microRNA‑23a and microRNA‑23b and the incidence and prognosis of ovarian cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8669
|
| 27 |
Anıl Delik, Sadık Dinçer, Hikmet Akkız. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene 2020; 24 doi: 10.1016/j.mgene.2020.100647
|
| 28 |
Mario Bartiromo, Michele Nardolillo, Serena Ferrara, Giuseppina Russo, Emanuele Miraglia Del Giudice, Anna Di Sessa. The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?. Expert Review of Gastroenterology & Hepatology 2023; 17(8) doi: 10.1080/17474124.2023.2242245
|
| 29 |
Mona A Hegazy, Ibrahim Abd ALgwad, Soheir Abuel Fadl, Mohamed Sayed Hassan, Laila Ahmed Rashed, Maha A Hussein. Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; doi: 10.2147/DMSO.S291595
|
| 30 |
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni. Nutrition and Genetics in NAFLD: The Perfect Binomium. International Journal of Molecular Sciences 2020; 21(8) doi: 10.3390/ijms21082986
|
| 31 |
Fatiha Nassir. NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules 2022; 12(6) doi: 10.3390/biom12060824
|
| 32 |
Epigenetics in Health and Disease - Part B. Progress in Molecular Biology and Translational Science 2023; 198 doi: 10.1016/bs.pmbts.2023.03.018
|
| 33 |
Dafei Xie, Peiwen Yuan, Dong Wang, Hua Jin, Hui Chen. Expression and prognostic significance of miR-375 and miR-221 in liver cancer. Oncology Letters 2017; 14(2) doi: 10.3892/ol.2017.6423
|
| 34 |
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2020; 14(8) doi: 10.1080/17474124.2020.1780915
|
| 35 |
Bo Zhang, Haijun Li, Dongwei Li, Hongzhi Sun, Mingqiang Li, Huawen Hu. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. Gene 2019; 700 doi: 10.1016/j.gene.2019.02.096
|
| 36 |
Hualin Wang, Yang Shao, Fahu Yuan, Han Feng, Na Li, Hongyu Zhang, Chaodong Wu, Zhiguo Liu. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model. BioMed Research International 2017; 2017 doi: 10.1155/2017/2503847
|
| 37 |
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
|
| 38 |
Zhila Bahramirad, Mohammad Raman Moloudi, Mohammad Moradzad, Alina Abdollahi, Zakaria Vahabzadeh. Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model. Biochemical Genetics 2025; 63(2) doi: 10.1007/s10528-024-10754-0
|
| 39 |
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes 2021; 9(1) doi: 10.3390/pr9010135
|
| 40 |
Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang. miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21. Journal of Cellular and Molecular Medicine 2016; 20(2) doi: 10.1111/jcmm.12733
|
| 41 |
Matthew Nayor, Svati H. Shah, Venkatesh Murthy, Ravi V. Shah. Molecular Aspects of Lifestyle and Environmental Effects in Patients With Diabetes. Journal of the American College of Cardiology 2021; 78(5) doi: 10.1016/j.jacc.2021.02.070
|
| 42 |
Jinkyung Cho, Jinhwan Yoon, Inho Park, Hyunsik Kang. Effect of Training Intensity on Hepatic Steatosis and Expression of miRNAs and Target Genes in a High-fat Diet-induced Mice. Exercise Science 2018; 27(1) doi: 10.15857/ksep.2018.27.1.32
|
| 43 |
Guan Wang, Haibo Zou, Chunyou Lai, Xiaolun Huang, Yutong Yao, Guangming Xiang. Repression of MicroRNA-124-3p Alleviates High-Fat Diet–Induced Hepatosteatosis by Targeting Pref-1. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.589994
|
| 44 |
Tripti Khare, Karina Liu, Lindiwe Oslee Chilambe, Sharad Khare. NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials. International Journal of Molecular Sciences 2025; 26(1) doi: 10.3390/ijms26010306
|
| 45 |
Chao Sun, Jian-Gao Fan, Liang Qiao. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(3) doi: 10.3390/ijms16035161
|
| 46 |
György Baffy. MicroRNAs in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2015; 4(12) doi: 10.3390/jcm4121953
|
| 47 |
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8) doi: 10.1053/j.gastro.2016.03.008
|
| 48 |
Prajakta C. Shimpi, Vijay R. More, Maneesha Paranjpe, Ajay C. Donepudi, Jaclyn M. Goodrich, Dana C. Dolinoy, Beverly Rubin, Angela L. Slitt. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. Environmental Health Perspectives 2017; 125(8) doi: 10.1289/EHP664
|
| 49 |
Jincheng Wang, Tao Qin, Jinyu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1046497
|
| 50 |
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8) doi: 10.1016/j.metabol.2015.12.012
|
| 51 |
Jun-Ke Long, Wen Dai, Ya-Wen Zheng, Shui-Ping Zhao. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Molecular Medicine 2019; 25(1) doi: 10.1186/s10020-019-0085-2
|
| 52 |
Fengqiong Liu, Ruijie Gong, Xiaofei Lv, Huangyuan Li. The expression profiling and ontology analysis of non-coding RNAs in dexamethasone induced steatosis in hepatoma cell. Gene 2018; 650 doi: 10.1016/j.gene.2018.01.089
|
| 53 |
Yong-Hong Zhang, Heng-Li Xie, Yu-Wei Yang, Jie Wen, Ran-Ran Liu, Gui-Ping Zhao, Xiao-Dong Tan, Zhen Liu, Yi Zheng, Jia-Bao Zhang. miR-375 upregulates lipid metabolism and inhibits cell proliferation involved in chicken fatty liver formation and inheritance via targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ). Poultry Science 2023; 102(1) doi: 10.1016/j.psj.2022.102218
|
| 54 |
Lide Arenaza, María Medrano, María Amasene, Beatriz Rodríguez-Vigil, Ignacio Díez, Manuel Graña, Ignacio Tobalina, Edurne Maiz, Edurne Arteche, Eider Larrarte, Inge Huybrechts, Catherine L. Davis, Jonatan R. Ruiz, Francisco B. Ortega, Javier Margareto, Idoia Labayen. Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial. Trials 2017; 18(1) doi: 10.1186/s13063-017-2117-y
|